Cargando…

Patient Phenotyping for Atopic Dermatitis with Transformers and Machine Learning

BACKGROUND: Atopic dermatitis (AD) is a chronic skin condition that millions of people around the world live with each day. Performing research studies into identifying the causes and treatment for this disease has great potential to provide benefit for these individuals. However, AD clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Andrew, Fulton, Rachel, Hwang, Sy, Margolis, David J., Mowery, Danielle L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491276/
https://www.ncbi.nlm.nih.gov/pubmed/37693571
http://dx.doi.org/10.1101/2023.08.25.23294636
Descripción
Sumario:BACKGROUND: Atopic dermatitis (AD) is a chronic skin condition that millions of people around the world live with each day. Performing research studies into identifying the causes and treatment for this disease has great potential to provide benefit for these individuals. However, AD clinical trial recruitment is a non-trivial task due to variance in diagnostic precision and phenotypic definitions leveraged by different clinicians as well as time spent finding, recruiting, and enrolling patients by clinicians to become study subjects. Thus, there is a need for automatic and effective patient phenotyping for cohort recruitment. OBJECTIVE: Our study aims to present an approach for identifying patients whose electronic health records suggest that they may have AD. METHODS: We created a vectorized representation of each patient and trained various supervised machine learning methods to classify when a patient has AD. RESULTS: The most accurate AD classifier performed with a class-balanced accuracy of 0.8036, a precision of 0.8400, and a recall of 0.7500 when using XGBoost (Extreme Gradient Boosting). CONCLUSIONS: Creating an automated approach for identifying patient cohorts has the potential to accelerate, standardize, and automate the process of patient recruitment for AD studies, therefore reducing clinician burden and informing knowledge discovery of better treatment options for AD.